Trial
NCT07133178
A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy Children
Phase IIIWITHDRAWNREGULATORYConfidence: HIGH
Sponsor
Valneva Austria GmbH
Collaborators
—
Condition
Chikungunya Virus Infection
Intervention
VLA1553
Why stopped
No participant recruited; trial initiation postponed to an unspecified future time while Valneva assesses potential pathways to address regulatory requests. Evaluation is ongoing to ensure alignment with regulatory expectations and obligations.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-31